JAMES CHARLES HIGHAM KESSLER
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology THORNTON, CO NPI 1003105636
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology CO Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$11,232.52
- Category: General Payments
- Program years: PY2018–2024
- Record count: 486
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,666.75 across 56 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,564.07 | 54 |
| Education | $102.68 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $318.82 | 7 |
| Braintree Laboratories, Inc. | $201.28 | 3 |
| PFIZER INC. | $185.19 | 5 |
| ABBVIE INC. | $167.70 | 12 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $152.34 | 8 |
| Regeneron Pharmaceuticals, Inc. | $146.49 | 1 |
| Gilead Sciences, Inc. | $124.09 | 5 |
| Regeneron Healthcare Solutions, Inc. | $76.82 | 2 |
| Celgene Corporation | $74.35 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $69.44 | 3 |
| Ardelyx, Inc. | $31.18 | 1 |
| CONMED Corporation | $28.37 | 1 |
| Celltrion USA Inc. | $27.69 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $23.09 | 1 |
| Organon LLC | $21.24 | 1 |
| GENZYME CORPORATION | $18.66 | 1 |
By program year
Records — PY2024 (56)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.